MEDS DataMeds AI, Inc.
$2.19▼ -1.79%
Healthcare
Other
Pre-market
$2.01▼ -8.22%
Oct 27, 7:52 AM ET
Volume 598.6K
Avg Volume (10D) 877.5K
Key Metrics & Fundamentals
Market Cap
$9.89M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.82 - 40.85
% vs 50 MA
-9.36%
% vs 200 MA
-64.89%
RSI-14
41.5
MACD Histogram
-0.1400
Beta (1Y vs SPY)
0.06
Free Cash Flow
-$3.14M
Gross Rev
$1.78M
Gross Profit
$182,204
EBITDA
-$6.48M
COGS
$1.60M
Operating Exp
$7.53M
Operating Income
-$7.35M
EBIT
-$7.35M
Pretax Income
-$18.36M
Net Income
-$18.36M
EPS (Diluted)
-7.13
Price & Volume History
Loading chart…
Recent News

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
ACCESS Newswire · Oct 23, 2026 6:45 AM ET

DataMeds Regains Compliance With NASDAQ Listing Standards
ACCESS Newswire · Oct 20, 2026 6:00 AM ET

DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
InvestorsHub · Oct 16, 2026 6:56 AM ET

DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
ACCESS Newswire · Oct 16, 2026 6:00 AM ET

DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
ACCESS Newswire · Oct 14, 2026 9:48 AM ET

DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
InvestorsHub · Oct 13, 2026 12:11 PM ET

DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
InvestorsHub · Oct 13, 2026 7:02 AM ET

DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
ACCESS Newswire · Oct 13, 2026 6:00 AM ET

DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
InvestorsHub · Oct 12, 2026 10:48 AM ET
Sector Update: Healthcare Stocks Higher Pre-Bell Monday
MT Newswires · Oct 12, 2026 9:20 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MEDS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.